Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Feb 4, 2007 at 1:37 PM EST

IBD Weekly Top Ranked Medical Stocks

From BioHealth Investor The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative…

Douglas A. McIntyre | Feb 4, 2007 at 1:35 PM EST

Biotech & Medical Venture Deals Roundup

by Adam Rubenstein Claros Diagnostics (Woburn, MA) is developing a handheld disease monitoring device that allows anyone to perform laboratory-quality…

Douglas A. McIntyre | Feb 2, 2007 at 4:18 AM EST

Thursday’s Top Biotech and Medical Stocks

Biotechnology SEATTLE GENETICS I [SGEN] +15.33% GILEAD SCIENCES [GILD] +11.21% CHELSEA THERAPEUTICS [CHTP] +11.01% SGX PHARMACEUTICALS [SGXP] +9.41% IDM PHARMA…

Douglas A. McIntyre | Feb 2, 2007 at 4:16 AM EST

Hollis-Eden Anti-Radiation Government Contract Delayed Again

by Andrew Vaino According to Greek mythology, after displeasing the gods, Sisyphus was consigned to spend eternity rolling a heavy…

Douglas A. McIntyre | Feb 2, 2007 at 4:14 AM EST

Allos Therapeutics Announces $50.5M Financing Deal

by Adam Rubenstein Lot’s of action transpiring at Allos Therapeutics (ALTH) since Paul Berns has taken over the reigns. We…

Douglas A. McIntyre | Feb 1, 2007 at 4:12 AM EST

Wednesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology IDERA PHARMACEUTICAL [IDP] +9.90% BIONOVO INC [BNVI.OB] +9.20% CHELSEA THERAPEUTICS [CHTP] +9.00% CURIS INC [CRIS] +7.58%…

Douglas A. McIntyre | Feb 1, 2007 at 4:10 AM EST

HIV Protection Trial Halted Due to Increase Risk of…HIV!

by H.S. AyoubBioHealth Investor.com Shares of Canadian firm Polydex Pharmaceuticals (POLYXF) absolutely sank more than 50% on Wednesday as the…

Douglas A. McIntyre | Jan 31, 2007 at 5:23 AM EST

Tuesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology PIPEX PHARMACEUTICAL [PPXP.OB] +42.50% BIONOVO INC [BNVI.OB] +15.87% NEUROBIOLOGICAL TECH [NTII] +13.93% REPROS THERAPEUTICS [RPRX] +10.24%…

Douglas A. McIntyre | Jan 31, 2007 at 5:22 AM EST

Companies Banking on Anti-Smoking Trend

by H.S. AyoubBioHealth Investor.com During the November elections three states, Ohio, Arizona and Nevada, passed tight smoking bans. Arizona’s anti-smoking…

Douglas A. McIntyre | Jan 30, 2007 at 3:59 AM EST

Monday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology NEURO-HITECH INC [NHPI.OB] +17.36% LEV PHARMACEUTICALS [LEVP.OB] +11.18% OBAGI MEDICAL [OMPI] +9.16% GENVEC INC [GNVC] +7.84%…

Douglas A. McIntyre | Jan 30, 2007 at 3:57 AM EST

Biotechs Ahead of Pharmas after All?

by H.S. AyoubBioHealth Investor.com In an earlier article, I reviewed Pisano’s book Science Business: the Promise, the Reality, and the…

Douglas A. McIntyre | Jan 29, 2007 at 6:25 PM EST

Cramer Defends Amgen (AMGN)

Another ‘Fallen Angel’ from Cramer on CNBC’s MAD MONEY is Amgen (AMGN-NASDAQ) after it got crushed last week. He said…

Douglas A. McIntyre | Jan 29, 2007 at 2:15 PM EST

Bristol-Myers’ Buyout Price? $28.35 Or Less to Options Prices

The talk of IF Bristol-Myers Squibb (BMY-NYSE) is really going to be gobbled up by Sanofi-Aventis (SNY-NYSE/ADR) hasn’t gone away,…

Douglas A. McIntyre | Jan 29, 2007 at 5:26 AM EST

Will A Sanofi Buy-Out Snatch Bristol-Myers From Its Misery

It would be one of the largest deals in the history of the drug industry. Perhaps the biggest, period. Late…

Douglas A. McIntyre | Jan 29, 2007 at 3:44 AM EST

Government Contract Could Set Hollis-Eden Stock Soaring

from BioHealth Investor The upcoming week will be a big one for Hollis Eden Pharmaceuticals (HEPH), a company I’ve written…

1 … 382 383 384 385 386 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

IBD Weekly Top Ranked Medical Stocks

Biotech & Medical Venture Deals Roundup

Thursday’s Top Biotech and Medical Stocks

Hollis-Eden Anti-Radiation Government Contract Delayed Again

Allos Therapeutics Announces $50.5M Financing Deal

Wednesday’s Top Biotech and Medical Stocks

HIV Protection Trial Halted Due to Increase Risk of…HIV!

Tuesday’s Top Biotech and Medical Stocks

Companies Banking on Anti-Smoking Trend

Monday’s Top Biotech and Medical Stocks

Biotechs Ahead of Pharmas after All?

Cramer Defends Amgen (AMGN)

Bristol-Myers’ Buyout Price? $28.35 Or Less to Options Prices

Will A Sanofi Buy-Out Snatch Bristol-Myers From Its Misery

Government Contract Could Set Hollis-Eden Stock Soaring

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Health and Healthcare Articles

All Health and Healthcare Articles

IBD Weekly Top Ranked Medical Stocks

Biotech & Medical Venture Deals Roundup

Thursday’s Top Biotech and Medical Stocks

Hollis-Eden Anti-Radiation Government Contract Delayed Again

Allos Therapeutics Announces $50.5M Financing Deal

Wednesday’s Top Biotech and Medical Stocks

HIV Protection Trial Halted Due to Increase Risk of…HIV!

Tuesday’s Top Biotech and Medical Stocks

Companies Banking on Anti-Smoking Trend

Monday’s Top Biotech and Medical Stocks

Biotechs Ahead of Pharmas after All?

Cramer Defends Amgen (AMGN)

Bristol-Myers’ Buyout Price? $28.35 Or Less to Options Prices

Will A Sanofi Buy-Out Snatch Bristol-Myers From Its Misery

Government Contract Could Set Hollis-Eden Stock Soaring

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s